Supernova Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The collaboration aims to bolster healthcare entrepreneurship
The award recognizes powerful science–industry collaborations for social good
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Achira is engaged in development and commercialization of PoC medical test kits in India
The company has posted net profit of Rs. 59.16 crores for the Financial Year ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated